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                                ABSTRACT
OBJECTIVE
                  To compare the effectiveness and advantages of using 
dexmedetomidine  and esmolol in induced hypotension for functional endoscopic 
sinus surgery.
METHODS
                 Fifty patients belonging to ASA 1 planned for  functional endoscopic 
sinus surgery  were randomly divided into two group’s. Dexmedetomidine group 
received a bolus dose of  1 microgram/kg  over 10 minutes  followed by infusion at 
a rate of 0.4-0.8 microgram /kg/hr. Esmolol group received a bolus dose of  1 
mg/kg over one minute followed by infusion at a rate of 0.4-0.8mg/kg/hr. The 
target mean arterial pressure was 55-65 mm hg. General anaesthesia was 
maintained with 60% N20:O2 .Induction dose of propofol, haemodynamic 
variable’s (blood pressure and heart rate) ,intra operative serum cortisol, quality of 
surgical field, emergence time, post anaesthesia recovery score(modified aldrete 
score>9), sedation score at 15 ,30 and 60 minute’s, time for rescue analgesia were 
recorded.
RESULT
               Dose of propofol was lower in dexmedetomidine group than esmolol 
group. Heart rate and blood pressure were comparable in both groups intra 
operatively ,when target mean arterial was achieved. Quality of surgical field and 
intra operative serum cortisol level’s were comparable in both group’s. Emergence 
time and time to achieve aldrete score > 9 were higher in dexmedetomidine group 
than esmolol group. Sedation score’s were higher in dexmedetomidine group than 
esmolol group at 15 ,30 minute’s post operatively. Time for rescue analgesia was 
prolonged in dexmedetomidine group than esmolol group.
CONCLUSION
                        The use of dexmedetomidine in induced hypotension for functional 
endoscopic sinus surgery has additional advantage of sedative ,analgesic and 
reduced requirement of anaesthetic agent’s than esmolol.
1INTRODUCTION
Functional endoscopic sinus surgery is one of the commonly 
performed Surgeries.
Induced hypotension is a method employed in  functional
endoscopic sinus surgery to reduce the blood loss and to improve 
visibility of the surgical field. Induced hypotension also helps in 
reducing blood transfusion during surgery.
Induced hypotension is also known as controlled hypotension 
(or)deliberate hypotension (or) hypotensive anesthesia. Induced 
hypotension also prevents progressive stretching of the vessel wall 
during vascular surgery, which enables easy suturing and clipping in 
aortic surgery , AV malformations and aneurysmal surgeries.
Esmolol is an ultrashort acting beta blocker and dexmedetomidine 
is a highly selective alpha 2 adrenergic agonist .
Hence,the above study was done in the department of 
anaesthesiology, chengalpattu medical college,Chengalpattu.
2AIM
The aim of the study was to compare the effectiveness and 
advantages of using dexmedetomidine and esmolol  in induced 
hypotension for functional endoscopic sinus surgery.
3HYPOTENSIVE ANESTHESIA
Induced   hypotension is a method employed to improve  the 
quality of the surgical field and to minimize the complications 
associated with blood transfusion.
HISTORY
 Induced hypotension was first proposed by Harving cushing for
neurosurgery in 1917.
 Gardner was the first to practice induced hypotension in surgery by 
arteriotomy.
 Griffith and gillies used high spinal anesthesia for producing 
Hypotension.
 Enderby used ganglionic blockers for induced hypotension and he 
also insisted on the importance of posture in induced hypotension.
 Sodium nitroprusside was first used hypotensive anesthesia by 
Moraca in 1962.
 Dimant used cardiac pacemakers for hypotensive anesthesia in 1967.
 Nitroglycerine and labetalol were used for induced hypotension in 
1970.
4PHYSIOLOGY OF INDUCED HYPOTENSION
During hypotensive anesthesia adequate blood flow should be 
maintained to vital organs in order to prevent end organ damage.Blood
flow to many vital organs such as heart,brain,kidneys and liver is 
autoregulated, which enables them to be perfused over a wide range of 
perfusion pressures.
OBJECTIVES 
 Maintain systolic blood pressure between 80-90mm hg.
 Maintain mean arterial pressure between 50-65mm hg.
 Maintain mean arterial pressure 30% of baseline value in 
hypertensive patients.
 A close communication between surgeon and anesthetist is necessary 
in order to maintain optimal surgical conditions without 
compromising end organ perfusion.
 Critical perfusion pressure varies for different organs and 
individuals.
CENTRAL NERVOUS SYSTEM
 Cerebral blood flow is autoregulated between 50-150mm hg.
5 During hypotensive anesthesia when cerebral blood flow reduces 
more the cerebral metabolic rate, cerebral ischemia develops.
 Volatile anesthetics used in hypotensive anesthesia attenuate the 
cerebral autoregulation.
 Vasodilators  used in hypotensive anesthesia attenuate the cerebral 
autoregulation.
 Head end elevation in hypotensive anesthesia also reduces the 
cerebral blood flow.
RESPIRATORY SYSTEM
 Ventilation perfusion mismatch can occur during hypotensive 
anesthesia due to use of head end elevation.
 Increase in paco2 can be due to inhibition of hypoxic pulmonary 
vasoconstriction leading to increase in intra pulmonary shunting.
 In order to avoid hypoxia higher fio2(0.4-0.5) should be used during 
hypotensive anesthesia.
CARDIOVASCULAR  SYSTEM
 Coronary blood flow decreases during hypotensive anesthesia, but 
corresponding decrease in myocardial oxygen demand prevents 
development of myocardial ischemia in healthy individuals.
6 Hypotensive anesthesia, when used in patients with coronary artery 
occlusion can cause redistribution of blood flow leading to 
myocardial infarction.
RENAL SYSTEM
 Hypotensive anesthesia causes decrease in glomerular filtration rate 
leading to oliguria in intraoperative period.
 Adequate hydration should be maintained in order to avoid 
postoperative renal dysfunction in hypotensive anesthesia.
HEPATIC SYSTEM
 Hepatic functions are not affected by hypotensive anesthesia.
7INDICATIONS
1) Neurosurgery-AV malformations, cerebral aneurysm surgery,
vascular tumour surgery, trans sphenoidal hypophysectomy.
2) Major orthopaedic surgery-total hip and knee replacement,spine 
surgery.
3) ENT surgery-functional endoscopic sinus surgery,middle ear 
surgery.
4) Head and neck surgery-faciomaxillary tumors, radical neck 
dissections, larygectomy.
5) Ophthalmic surgery-orbital surgery , vitrectomy, intraocular tumors
6) Major pelvic and gynaecological surgeries
7) Plastic and reconstructive surgery
8) Jehovas witness
8CONTRAINDICATIONS
1) Ischemic heart disease
2) Cerebrovascular disease
3) Hepatic dysfunction 
4) Renal dysfunction
5) Severe respiratory disease
6) Diabetes mellitus
7) Uncontrolled hypertension
8) Bleeding diathesis
9) Allergy to hypotensive agents
10) Severe anemia
11) Lack of knowledge of the technique
12) Lack of adequate monitoring
13) Patient refusal
9METHODS OF HYPOTENSIVE ANESTHESIA
PHYSICAL MEASURES
 Head end elevation-Elevation of head end of the patient helps to 
prevent blood loss during surgery, but head end elevation is 
associated with the risk of air embolism.
 Head end elevation causes pooling of blood in the lower extremities 
leading to decrease in venous return to the heart and cardiac output.
 Positive pressure ventilation-Positive pressure ventilation reduces 
venous return to the heart, which can be further reduced by 
prolonging the inspiratory time and by applying positive end 
expiratory pressure.
PHARMACOLOGICAL AGENTS
Characteristics of a ideal hypotensive agent
 Easy to administer
 Rapid onset of action
 Hypotensive effect should disappear rapidly on discontinuation
 Rapid elimination
 No toxic metabolites
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 Negligible effect on vital organs
 Predictable effect
 Dose dependant effect
GANGLIONIC BLOCKING AGENTS
 They produce hypotension by blocking both sympathetic and 
parasympathetic outflow from autonomic ganglia.
 Pentamethonium and hexamethonium were initially used in 
hypotensive anesthesia.
 Pentolinium is a highly potent agent, devoid of tachycardia due to 
effective sympathetic blocking  action.
 Trimethaphan has additional direct vasodilating property and 
histamine releasing property , which enhances it’s hypotensive 
effect.
 Trimethaphan has very short duration of action of 1-2 min’s and it 
is metabolised by plasma cholinesterase.
ALPHA  ADRENERGIC  BLOCKERS
 Alpha blockers produce hypotension by blocking alpha 1 receptors in 
blood vessels leading to vasodilatation.
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 Phentolamine is a short acting alpha blocker used in hypotensive 
anesthesia.
 Phentolamine has rapid onset of  action ,it’s plasma level reaches a 
peak within 2 min’s.
 Phentolamine is usually administered in bolus doses of 2 -5 mg.
 Labetalol is a combined alpha and beta blocker.
 Labetalol has more potent action on beta receptors when compared 
with alpha receptors.
 Labetalol has rapid onset of action with peak plasma concentrations 
reaching within 5 min.
 Advantages of labetalol include lack of rebound hypertension, lack 
of tachycardia, tachyphylaxis.
 Contraindications for labetalol are patients with heart block,
bradycardia, conduction block, congestive cardiac failure and  
hypovolemia.
VASODILATORS
1) SODIUM NITROPRUSSIDE
 Mechanism of action-sodium nitroprusside acts by production of 
nitric oxide.Nitric oxide diffuses across the cell membrane and 
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stimulates guanylate cyclase, which inhibits intracellular release of 
calcium leading to relaxation.
 Nitroprusside has rapid onset of action within 1 min.
 Dose of nitroprusside is 0.5-10 microgram/kg/min.
 Metabolism-Cyanide released from nitroprusside combines with 
thiosulfate to form thiocyanate in the liver  in the presence of enzyme 
rhodanase. Cyanide also combines with hydroxylcobalamine to form 
cyanocobalamine.
 Complication-Important complication associated with nitroprusside 
is cyanide toxicity.
 Cyanide can combine with cytochrome oxidase in the electron 
transport chain leading to histotoxic hypoxia.
 Manifestations of cyanide toxicity
1) Resistance to high infusion doses of  nitroprusside
2) Metabolic acidosis
3) Elevated lactate levels
4) Hypotension not responding to fluids and  vasopressors
5) Cardiovascular collapse
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 Management of cyanide toxicity
1) Sodiumthiosulphate-it converts cyanide to thiocyanate and 
enables it’s excretion.It is given as a bolus dose of 30mg/kg 
followed by infusion at a rate of 60 mg/kg/hr.
2) Hydroxocobalamine-it prevents increase in concentration of 
cyanide in erythrocytes. it is given as a bolus dose of 50mg/kg 
followed by infusion at a rate of 100 mg/kg/hr.
3) Sodium nitrite (or)amyl nitrite-it produces methemoglobin , 
which combines with cyanide to form cyanomethemoglobin. It is 
administered at a dose of 5mg/kg intravenously.
NITROGLYCERINE
 Nitroglycerine is predominantly a venodilator, it reduces venous 
return to the heart and produces hypotension.
 Dose of nitroglycerine is 0.5-10 microgram/kg/min.
 It has rapid onset of action and a short half life of about 2 min.
 Advantages of nitroglycerine is that it does not produce any 
toxicmetabolites and it does not produce rebound hypertension.
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HYDRALAZINE
Hydralazine is predominantly a arterial vasodilator used to 
producehypotension.
NICARDIPINE
 Nicardipine is a calcium channel  blocker used in  
inducedHypotension.
 Nicardipine is given intravenously and it has a distribution half life 
of14 min.
 Nicardipine should be cautiously used in patients with renal 
dysfunction .
ADENOSINE
 Adenosine is a potent vasodilator used in induced hypotension.
 Adenosine has a very short half life of 10-20 sec.
 Adenosine causes decrease in peripheral vascular resistance without 
causing increase in heart rate.
 Adenosine is infused at a rate of 6o-300microgram/kg/min.
 Advantages of adenosine is that it does not produce any rebound 
hypertension.
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 Disadvantages –It can block the conducting system of heart leading
to bradycardia. It can cause coronary steal phenomenon. It cancause 
accumulation of uric acid in patient with gout.
PROSTAGLANDIN E1
 Prostaglandin E1 has positive inotropic action on the heart and it 
causes a decrease  in systemic vascular resistance.
 Prostaglandin E1 has antiarrythmic  action.
 Prostaglandin E1 helps in maintaining cerebral autoregulation.
 ProstaglandinE1 used in induced hypotension  helps in increasing 
renal blood flow and urine formation.
INHALATIONAL AGENTS
 Inhalational agents like halothane, isoflurane, sevoflurane, desflurane 
can be used in induced hypotension.
 Halothane is a direct myocardial depressant and it sensitizes the heart 
to arrythmogenic action of adrenaline.
 Isoflurane produces hypotension by decreasing the systemic vascular 
Resistance.
 Sevoflurane and desflurane are newer inhalational agents which 
produce hypotension without significant myocardial depression.
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BETA BLOCKERS
 Beta blockers produce hypotension by decreasing the myocardial 
contractility and cardiac output.
 Propanolol is a non selective beta blocker used in hypotensive 
anaesthesia. It is administered at a dose of 0.5mg intravenously.
Propanolol can produce bronchospasm in patients with bronchial 
asthma.
 Metaprolol is a selective beta1 blocker used in induced hypotension.
 Esmolol is a ultrashort acting selective beta 1 blocker used in 
induced hypotension.
REMIFENTANIL
 Remifentanil is a ultra short acting opiod used in hypotensive 
anesthesia.
 Remifentanil has a ester group and hence it is metabolized by plasma
and RBC esterases.
 Remifentanil has a short context sensitive half life of about 4 
minutes.
 Remifentanil is given at a loading dose of 1microgram/kg/min.
 Remifentanil can also be used to blunt the sympathetic 
responseassociated  with laryngoscopy and intubation.
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MONITORING IN HYPOTENSIVE ANESTHESIA
 Invasive blood pressure-Intra arterial blood pressure monitoring is 
gold Standard during hypotensive anesthesia for accurate  
measurement of blood  pressure.
 ECG-Ecg is mandatory during hypotensive anesthesia to detect 
anycompromise in coronary blood flow.
 Pulse oxymeter-pulse oxymeter is used to make changes in FIO2 due 
toventilation perfusion mismatch occurring during hypotensive 
anesthesia.
 ETCO2-Etco2 is essential as it can be useful in estimation of blood 
PaCO 2 during hypotensive anesthesia.
 Temperature-Temperature should be monitored to detect 
hypothermia during hypotensive anesthesia.
 Urine output-urine output should be monitored to assess  the 
adequacy of renal perfusion during hypotensive anesthesia.
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FUNCTIONAL ENDOSCOPIC SINUS SURGERY
 Functional endoscopic sinus surgery is a technique to a gain access to  
paranasal sinuses by minimal invasive methods .
 The main aims of sinus surgery is to provide drainage to the sinus 
cavities and to obtain tissues from sinus cavity for pathological 
examination.
INDICATIONS
1) Chronic sinusitis-The most common indication of endoscopic sinus 
is     chronic  sinusitis refractory to medical treatment.
2) Turbinate reduction-Endoscopic sinus surgery is used for reduction 
of hypertrophied turbinates causing nasal obstruction.
3) Septoplasty-Deviated nasal septum causing nasal obstruction can be 
corrected by endoscopic sinus surgery.
4) Control of epistaxis-Endoscopic sinus surgery is useful in 
identification and ligation of blood vessels responsible for epistaxis.
5) Orbital decompression-Orbital decompression in patients with 
exophthalmos can be performed using endoscopic sinus surgery.
6) Repair of CSF leak-Endoscopic sinus surgery is used in repair of 
CSF leaks occurring through the anterior skull base.
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7) Pituitary surgery-Endoscopic sinus surgery is used in performing   
transsphenoidal hypophysectomy.
COMPLICATIONS OF ENDOSCOPIC SINUS SURGERY
1. Injury to nasolacrimal duct can lead to excessive tearing in the post 
operative period.
2. Injury to medial wall of orbit can occur leading to prolapse of orbital 
fat and orbital haemorrhage.
3. Injury to cribriform plate of ethmoid can lead to leakage of CSF
4. Surgeries involving sphenoid sinus can lead to injury to carotid 
artery and optic nerve.
5. Surgeries involving frontal sinus can also result in leakage of 
cerebrospinal fluid.
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ANESTHETIC CONSIDERATIONS IN ENDOSCOPIC SINUS 
SURGERY
PRE OP PREPARATION
Patients undergoing endoscopic sinus surgery are premedicated
with nasal decongestant drops like xylometazoline to reduce bleeding 
.Steroids  like dexamethasone are given preoperatively to reduce nasal 
edema in the postoperative period .
INTRAOPERATIVE  MANAGEMENT
Endoscopic sinus surgery can either be performed under local 
anesthesia or monitored anesthesia care or general anesthesia. In 
patients with extensive disease, involvement of multiple sinuses  and in 
patients with reactive  airway disease  surgery is preferably performed 
under general anaesthesia. Laryngeal mask airway can be used instead 
of an endotracheal tube  as it prevents entry of blood into the 
stomach.Laryngeal mask airway is particularly useful in patients with 
reactive airway disease as it prevents coughing or buking during 
emergence ,which can lead to bleeding from the surgical site.
Maintainance of a bloodless field is essential during sinus surgery 
to improve visualization of the surgical field. It can achieved by placing 
pledgets soaked  with vasoconstrictive agents like adrenaline or 
xylometazoline in the  nasal cavity or by blocking the sphenopalantine
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ganglion using infiltration with 1% lignocaine and 1:1,00,000 
epinephrineor by inducing hypotension with hypotensive agents.
POSTOPERATIVE MANAGEMENT 
Patients undergoing endoscopic sinus surgery should be 
monitored  in the post op period as they are at the risk of aspiration of 
the swallowed blood .Pain relief  should be given  in the post op period 
using opioids.   
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PHARMACOLOGY OF ESMOLOL
Esmolol is a cardioselective ultra short acting beta blocker.The
chemical name of esmolol is methyl p-[2-hydroxy-3-
(isopropylamino)propoxy] hydrocinnamate hydrochloride.
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CLINICAL PHARMOCOLOGY OF ESMOLOL
Esmolol is a short acting agent with a elimination half life of 9 
minutes .Though esmolol is a cardioselective beta blocker at higher 
doses it acts on beta 2 receptors present in bronchial smooth muscles 
and blood vessels. 
PHARMACOKINETICS AND METABOLISM
Esmolol is metabolized by RBC esterases into free acid and
methanol. The acid metabolite is excreted through urine and hence in 
patients with limited renal reserve,the elimination half life of esmolol is
prolonged. The rate of clearance of esmolol was 20L/kg/hr, which is 
greater than the cardiac output and it’s metabolism is not affected by 
rate of blood flow to the liver and kidneys.
Esmolol is administered at a loading dose of 1 mg/kg and the 
infusion dose of esmolol is 0.05-0.3mg/kg/min. With loading dose 
steady state plasma concentration is achieved within 5 min’s. With
infusion steady state plasma concentration is achieved in 30 min.
PHARMACODYNAMICS
Esmolol causes decrease in heart rate, delay in recovery of sinus 
node,Prolongation of AH interval during normal sinus rhythm and 
increase in antegrade wenckebach cycle length.
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During exercise esmolol produces decrease in heart rate,blood
pressure, rate pressure product,right and left ventricular ejection fraction 
and cardiac index. Discontinuation of esmolol is associated with return 
of parameters to baseline in about 30 minutes. Esmolol did not produce 
any adverse reactions in patients with bronchial asthma and COPD.
INDICATIONS
1) Supraventricular tachycardia-Esmolol is used in rapid control of 
ventricular rate in patients with atrial fibrillation and atrial flutter.
2) Intraoperative and postoperative tachycardia and hypertension
Esmolol is used to blunt the tachycardia and hypertension associated 
with laryngoscopy and intubation and during emergence from 
anesthesia.
For control of intraoperative tachycardia and hypertension 
esmolol is administered at a of loading dose of 1mg/kg over one minute 
followed by infusion at a of 150microgram/kg/min. 
CONTRAINDICATIONS
1) Heart block
2) Sinus bradycardia
3) Congestive cardiac failure
4) Cardiogenic shock
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ADVERSE EFFECTS
 Cardiovascular  system
Esmolol can produce hypotension, bradycardia, chest pain 
pulmonary edema, peripheral ischemia, syncope, heart block and even 
asystole.
 Central nervous system
Headache,paraesthesia,dizziness,anxiety,depression,asthenia,som
nolence,lightheadedness,abnormal thinking, agitation and fatigue.
 Respiratory system
Bronchospasm, dyspnoea, wheezing, rhonchi and nasal 
congestion can occur.
 Gastrointestinal system
Dyspepsia, nausea and vomiting,constipation and abdominal 
discomfort can occur.
 Skin
Discoloration ,edema, erythema,thrombophlebitis and skin 
necrosis can occur.
 Miscellaneous
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Retention of urine, visual disturbance, speech disorder,fever and 
rigors can occur.
DRUG INTERACTIONS
1) Administration of esmolol with morphine resulted in increase in 
plasma concentrations of esmolol.
2) Pharmacokinetics of esmolol was not affected by concomitant 
administrationof digoxin and warfarin.
3) Concomitant administration of esmolol and reserpine resulted in 
worsening of bradycardia  and hypotension.
4) Esmolol can cause prolongation of neuromuscular blockade caused 
by administration of succinyl choline.
5) Esmolol should be cautiously used in patients on calcium channel 
blockers like verapamil as it lead to heart block and cardiac arrest.
6) Esmolol should be cautiously used along with vasopressors like 
dopamine, dobutamine and noradrenalin as myocardial contractility 
can be impaired.
7) Esmolol should be cautiously used in patients  who are already on 
drugs  which impair myocardial contractility.
8) Patients on esmolol require a higher dose of epinephrine to treat 
anaphylactic reactions.
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TOXICITY
Esmolol overdose can cause cardiac arrest.Use of premixed 
injections can avoid the dilutional errors  occurring with esmolol.
Management
1) Hypotension should be treated with  intravenous fluids and 
vasopressors.
2) Bradycardia should be treated with intravenous atropine.
3) Bronchospasm should be treated with beta2 agonists.
4) Cardiogenic shock should be treated with inotropic agents like 
dopamine, dobutamine, isooprenaline or using inodilators like 
milrinone.
PRECAUTIONS
1) Esmolol should be cautiously used in diabetic patients as it can mask 
the symptoms of hypoglycemia.
2) Esmolol should be avoided in patients with end stage renal disease as 
the plasma concentrations of esmolol can get elevated in patients 
with renal disease.
3) Esmolol should be cautiously used in patients with bronchial asthma 
as bronchospasm can occur.
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4) Esmolol should be avoided in pregnancy as fetal bradycardia can 
occur.
5) Esmolol should be avoided in nursing mothers as esmolol is excreted 
in breast milk.  
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PHARMACOLOGY OF DEXMEDETOMIDINE
Dexmedetomidine is a selective alpha-2 agonist which has 
sedative and analgesic properties.  
31
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PHARMACODYNAMICS
Dexmedetomidine  is selective for alpha 2 receptors but at higher 
doses it also has alpha 1 action. The sedative properties of 
dexmedetomidine are mediated through action on post synaptic alpha 2 
receptors in locus caerulus in brain and spinal cord. Dexmedetomidine
has also action on muscarinic, dopaminergic, adrenergic and serotonin 
receptors.
PHARMACOKINETICS
Dexmedetomidine has a distribution half life of about 6minutes 
and a elimination half life of about 2 hours. The volume of distribution 
is 118 litres and it is highly protein bound .
Metabolism-Dexmedetomidine is predominantly metabolized in 
the liver into inactive metabolites. Metabolism occurs through 
glucuronidation and through cytochrome p450 pathways.Context 
sensitive half life of dexmedetomidine is 4 to 10 minutes.
Elimination
Elimination of dexmedetomidine takes place through the kidneys 
and hence dexmedetomidine should be cautiously used in patients with 
severe renal impairment.
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INDICATIONS
1. Dexmedetomidine is principally used for sedation of mechanically 
ventilated patients in the ICU. Dexmedetomidine has the advantage 
of producing sedation without significant respiratory depression.
2. Dexmedetomidine can also be used for sedation during surgical 
procedures in monitored anaesthesia care.
3. Dexmedetomidine can be used for rapid opioid detoxification,
cocainewithdrawal and intolerance after prolonged use of 
benzodiazepines and opioids.
4. Dexmedetomidine can also be used in awake fiber optic intubation,
awake craniotomies with functional testing and electrocorticography 
and in awake carotid endarterectomies with stable haemodynamics.
CONTRAINDICATIONS
1. Contraindicated in patients with severe hepatic and renal 
dysfunction.
2. Patients with known hypersensitivity to dexmedetomidine.
DOSE
Dexmedetomidine is administered at a loading dose of 
1microgram/kg followed by infusion at a rate of 0.5 micrograms/
kg/hour. 
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Infusion dose can be increased by 0.1 microgram/ kg/hour every 5 
minutes if adequate clinical response is not obtained. Elderly patients 
are highly sensitive to dexmedetomidine, Hence the dose of 
dexmedetomidine should be reduced. Effects of dexmedetomidine can 
be antagonized by administration of atipamazole.
ADVERSE EFFECTS
The common adverse effects of dexmedetomidine are 
hypotension, bradycardia, dryness of mouth, hypertension and nausea.
Other adverse effects include fever, arrhythmias like atrial 
fibrillation,edema, myocardial infarction, pulmonary edema, speech 
disorders, diarrhoea, hyperkalemia, hyperglycemia, muscle weakness, 
paraesthesia, delirium, hallucinations, depression, urinary retention, 
hypoxia, hypercapnia, hypoventilation, pulmonary hypertension, 
pneumothorax, erythematous rashes and visual disturbances. 
Administration of dexmedetomidine is associated with elevation 
of liver enzymes and decrease in prothrombin levels. Dexmedetomidine 
canproduce withdrawal syndrome after discontinuation.
DRUG INTERACTIONS
Dexmedetomidine enhances the effects of anaesthetic agents such 
as hypnotics, sedatives and opioids. Hence, co-administration of these 
drugs with dexmedetomidine results in decrease in dose requirement of 
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these agents. Caution should be exercised during administration of 
dexmedetomidine along with vasodilators and negative inotropic agents
as it can worsen bradycardia and hypotension associated with
dexmedetomidine. Dexmedetomidine should be avoided in pregnancy 
and during labour and caesarean section. 
Dexmedetomidine should be avoided in nursing mothers as it is 
excreted in breast milk.
PRECAUTIONS
Close monitoring of the patient with ECG, Pulse oxymeter and 
Blood pressure monitoring should be done during administration of 
dexmedetomidine.
Caution should be exercised while administering 
dexmedetomidine to patients with pre-existing heart block, Congestive
cardiac failure and bradycardia.
Patient should be adequately hydrated prior toadministration of 
dexmedetomidine to prevent hypotension. 
Treatment of hypotension includes stoppage of the infusion, 
elevationof the foot end of the patient and administration of 
vasopressors.
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Administration of loading dose of dexmedetomidine can be 
associated with transient hypertension. This occurs due to action on 
alpha 1 receptors in blood vessels due to the high plasma concentration 
attained during administration of the loading dose.
Rapid intravenous administration of dexmedetomidine to 
individuals with high vagal tone can cause severe bradycardia and 
cardiac arrest. Treatment of bradycardia involves administration of 
anticholinergic agents such as atropine or glycopyrolate.
Administration of dexmedetomidine can cause dryness of eyes 
and hence patient’s eyes should be lubricated to prevent corneal dryness. 
Sudden discontinuation of dexmedetomidine after prolonged 
infusion can cause withdrawal syndrome characterized by rebound 
hypertension, headache, agitation and nervousness. Henceinfusion of 
dexmedetomidine should be limited to less than 24 hours.
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REVIEW OF LITERATURE
Boezaart et al (1995) in a prospective study of forty patients to 
compare the effects of sodium nitroprusside and esmolol in controlled 
hypotension for functional endoscopic sinus surgery. They found that in 
esmolol group ,due to unopposed alpha adrenergic effect on mucous 
membrane superior surgical conditions were obtained with mild 
hypotension(MAP>65 mmhg) when compared with nitroprusside group.
Koi io et al(2009)  in a prospective double blinded study of 48 
patients  to compare the effects of combining desflurane with esmolol
and dexmedetomidine in controlled hypotension for tympanoplasty
surgery found that both esmolol and dexmedetomidine can be 
effectively used along with desflurane  for tympanoplasty surgery and 
esmolol group had shorter recovery time and less post operative
sedation when compared with dexmedetomidine group.
Turan et al(2007) in a prospective randomized study of patients 
to compare  the effects of dexmedetomidine, remifentanil and esmolol in 
controlled hypotensive anesthesia found that no significant differences 
were seen between threegroups with respect to quality of surgical field 
and intra operative MAP and heart rate but post extubation values were 
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significantly lower in remifentanil and esmolol group  when compared 
with dexmedetomidine group.
Baysoni et al  (2013) in prospective randomized study  for 
comparison of remifentanil and esmolol in induced hypotension for 
nasal surgery in 30 patients found no significant differences between the 
two groups with respect to intra operative surgical field and vital 
parameters like  MAP and heart rate and concluded that remifentanil and
esmolol provided dry surgical fields during nasal surgery.
Y j lim et al(2003) in a study to compare esmolol with esmolol 
and normovolemic haemodilution for controlled hypotension in 30 
patients undergoing spinal surgery found that transfusion of blood 
products in esmolol normovolemic haemodilution group was 
significantly lower when compared with esmolol alone group and 
concluded that esmolol in combination with normovolemic
haemodilution can be effectively used for blood conservation in spinal 
surgeries.
Celebi et al(2007) in a prospective study of comparison of 
esmolol and remifentanil  on cognitive functions during induced 
hypotension  for tympanoplasty surgeries  found that both remifentanil
and esmolol provided ideal surgical  conditions  and they produced 
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similar effects on cognitive function in the immediate post operative
period.
Guney et at(2002)  in a prospective study of esmolol compared 
with nitroglycerine for controlled hypotension in patients undergoing 
nasal surgeries  found  that ideal surgical conditions and better 
heamodynamic stability was provided with esmolol than nitroglycerine.
They concluded that esmolol can be effectively used as alternative to 
nitroglycerine for controlled hypotension.
Eun et al(1997) in a comparative study between sodium 
nitroprusside and esmolol with induced hypotension for total hip 
arthroplasty in 70 patients found there were  no significant differences 
between the two groups with respect to blood loss,blood transfusion and 
fluid administration  and concluded that esmolol can be effectively used 
as an hypotensive agent in hip arthroplasties without significant side 
effects.  
Gokce et al (2009) in prospective randomized double blinded 
studywith 40 patients of hypotensive anesthesia with esmolol  for 
assessment of haemodynamics and consumption of anesthetic agentsand 
recovery  studied the effects of adding esmolol to propofol and 
remifentanil combination in controlled hypotension and concluded that 
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the addition reduced the requirement of remifentanil without decrease in 
cardiac output.
Kumsuk park et al(2006) in a prospective study of hydralazine 
pretreatment in patients undergoing controlled hypotensive anesthesia 
with esmolol in spine surgery found  that time required to achieve the 
target mean arterial pressure was significantly lowered in the group,
which had hydralazine pretreatment than esmolol alone group without 
any decrease in cardiac output and concluded that addition of 
hydralazine increases the efficacy of esmolol and decreases it’s dose 
requirement without decrease in cardiac output.
Himanshudongre et al(2012) in a study of controlled 
hypotensive anesthesia  comparing esmolol and nitroglycerine in 
producing a dry operating field for spinal surgery found that the heart 
rate  and  mean arterial pressure required for ideal surgical field were 
significantly lower in esmolol group than nitroglycerine group.
Erbesler et al (2013) in  a prospective study  compared  the 
effectiveness of dexmedetomidine and esmolol in induced  hypotension
on clinical course and cost and  found that the recovery index and 
duration of clinical action were significantly prolonged in 
dexmedetomidine group than esmolol group and concluded that both 
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drugs can be used in induced hypotension but neuromuscular blocking 
time was prolonged in dexmedetomidine group. 
Mengistu et al (2007) studied the effects of sodium nitroprusside 
and esmolol used in induced hypotension on natriuretic peptides in 45 
patients undergoing endoscopic nasal surgery. Patients were divided into 
three groups (control, esmolol, nitroprusside group),they found that 
levels of ANP(atrial natriuretic peptide)and BNP(brain natriuretic 
peptide) were significantly lower in nitroprusside and esmolol group 
than control group and concluded that decreasein natriuretic peptide 
levels  were due to decrease in cardiac filling pressures due to decrease 
in systemic vascular resistance associated with hypotensive anaesthesia.
Zhou qi et al(2010) in a prospective study  evaluated the effects 
of Combining esmolol with nitroglycerine for induced hypotension in 
Hypertensivepatients undergoing spinal surgery  and concluded that the 
addition of esmolol with nitroglycerine has decreased blood loss in the 
intraoperative period and the duration of surgery.
Akkaya et al(2014) in a randomized clinical study  compared the 
effects of dexmedetomidine and magnesium sulphate  on the quality of 
surgical field in patients undergoing endoscopic sinus surgery. They 
found that heart rate and duration of surgery were significantly lower in 
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dexmedetomidine group, and the quality of surgical field was much 
better in dexmedetomidine group than magnesium sulphate group. They
concluded that dexmedetomidine was a much better alternative to 
magnesium sulphate for induced hypotension. 
Shen et al (2001) in a double blinded randomized control 
trail,Studied the effects of intra operative esmolol infusion on quality of 
surgical fields during sevoflurane anesthesia in 40 patients undergoing 
endoscopic sinus surgery. The patients were divided into two groups 
,one received esmolol infusion and other received saline infusion along 
with inhalational agent sevoflurane. They found that heart rate and 
blood pressure  were significantly lower in esmolol group and thequality 
ofsurgical field was better in esmolol group. They also found that 
bloodloss was much lower in esmolol group. They concluded that intra 
operative infusion of esmolol produced bradycardia and hypotension 
and the quality of surgical field was significantly improved in patients 
undergoing endoscopic sinus surgery.
Abdulla aydin ozcan et al (2012) in a randomized prospective 
study Compared remifentanil and dexmeditomidine for induced 
hypotension in 50 patients undergoing endoscopic  sinus surgery. They 
found that heart rate was higher in remifentanil group than 
43
dexmedetomidine group and the recovery time was prolonged in 
dexmedetomidine group than remifentanil group. They concluded that 
both remifentanil and dexmedetomidine can be effectively used for 
producing improved qualityof surgical field in patients undergoing 
endoscopic sinus surgery but dexmedetomidine was associated with 
prolonged recovery time than remifentanil.
Farah nasreen et al(2009) studied the effects of using 
dexmedetomidine for controlled hypotension in 42 patients undergoing 
middle earsurgery.The patients were divided into two groups,one 
received infusion of dexmedetomidine and other group received saline 
infusion. The target mean arterial pressure was achieved with 
halothane.They found that the requirement of halothane to achieve  the 
target mean arterial pressurewas much lower in dexmedetomidine group 
and surgical field quality was much better in dexmedetomidine group.
They concluded that hypotensiveanesthesia can be safely provided in 
patients undergoing  middle ear surgery with dexmedetomidine.
Richaf et al (2008)in a prospective study compared 
dexmedetomidine with remifentanil in controlled hypotension for 
patients undergoing tympanoplasty. They concluded that 
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dexmedetomidine can be safely used as an alternative to remifentanil for 
providing hypotensive anesthesia in tympanoplasty surgery.
Bayazit dikmen et al(2010)studied the effects of using 
dexmedetomidine with low flow anesthesia for controlled hypotension 
in 40 patients undergoing middle ear surgery.The patients were divided 
into two groups, one received dexmedetomidine infusion and another 
group received saline infusion. They found that the dexmedetomidine 
group achieved target mean arterial pressure earlier than saline 
group.They concluded that dexmedetomidine effectively produced 
sustained hypotension with low flow anesthesia in patients undergoing 
middle ear microsurgery.
Malhotra et al(2013)in a prospective study,studied the effects of 
dexmedetomidine in improving the quality of surgical field and the 
requirement of hypotensive agents  in 60 patients undergoing 
endoscopic sinus surgery under general anaesthesia. Patients were 
divided into two groups,one received dexmedetomidine infusion and 
another received saline infusion and found that nitroglycerine needed to 
achieve target mean arterial pressure was lower in dexmedetomidine 
group and mean arterial pressure  was significantly lower in 
dexmedetomidine group. They concluded that better quality surgical 
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field can be provided with hypotensive anesthesia using 
dexmedetomidine.
Guang jiegao et al(2012)studied the feasibility of 
dexmedetomidine for induced hypotension in 48 patients undergoing 
endoscopic sinus  surgery with sevoflurane. The patients were divided 
into two groups, dexmedetomidine group and saline group. They found 
that the dose of anesthetic agents like propofol, sevoflurane and fentanyl 
were significantly lower in dexmedetomidine group ,mean arterial 
pressure and heart rate were also significantly lower in 
dexmedetomidine group, incidence of shivering and delirium were also 
lower in dexmedetomidine group but the incidence of bradycardia was 
higher in dexmedetomidine group. They  concluded that 
dexmedetomidine provided cardiovascular stability and reduced the 
intraoperative requirement of anesthetic agents and was effective for 
hypotensive anesthesia in endoscopic sinus surgery.
Sunil chiruvella et al(2014)made a prospective randomized 
double blinded study with dexmedetomidine for controlled hypotensive 
anesthesia in endoscopic sinus surgery.They found that duration of 
surgery and mean arterial pressure were lower in dexmedetomidine 
group and the quality of surgical field was better in dexmedetomidine
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group. They concluded that dexmedetomidine can be safely used for 
induced hypotension during endoscopic sinus surgery.
Gurbet et al (2006) studied the effects of intraoperative infusion 
of dexmedetomidine on perioperative analgesic requirements in 50 
patients.Thepatients were divided into two groups,one group received 
dexmedetomidine infusion  and another group received saline infusion . 
They found that requirement of morphine in the post operative 
period was significantly lower in dexmedetomidine group. They 
concluded that intra operative use of dexmedetomidine provides 
effective post operative analgesia  and reduces analgesic requirement in 
the post operative period without increasing side effects.
Kim sy et al(2013) studied the effects of intraoperative use of 
dexmedetomidine infusion on agitation during emergence  and recovery 
quality after nasal surgery in 100 patients. Patients were divided into 
two groups, one received dexmedetomidine infusion  and another 
received saline infusion. They found that emergence agitation was lower 
in dexmedetomidine group and heart rate and blood pressure were lower 
in dexmedetomidine group.24 hours after surgery  global –QOR-40 
score  was higher in dexmedetomidine group. They concluded that intra 
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operative infusion of dexmedetomidine resulted in better recovery  and 
smooth emergence after nasal surgery. 
Guray demir et al(2009) studied the effects of dexmedetomidine 
on heamodynamic parameters  and dose of propofol during anesthetic 
induction in 80 patients. Patients were divided into two groups, one 
group received dexmedetomidine and another group received saline. 
They found that mean arterial pressure and heart rate were significantly 
lower in dexmedetomidine group, the dose of propofol was also lower in 
dexmedetomidine group. They concluded  the use of propofol before 
induction blunted heamodynamic response associated with 
laryngoscopy and intubation,it also reduced the requirement of propofol.
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MATERIALS & METHODS
The study was a prospective randomized single blinded control 
trial involving 50 patients (25 in each group) attending the Department 
of Ear, nose and Throat, Chengalpattu Medical College Hospital over a 
period of one year(July 2013 – June 2014). Institutional ethical
committee approval was obtained.  The procedure was explained to the 
patient. Informed consent was obtained. Detailed history of the patient 
was collected. Routine investigations like complete blood count, blood 
glucose, renal function tests, serum electrolytes, chest x ray, 
electrocardiogram were done as per our hospital protocol. Patients 
fulfilling the inclusion criteria and who gave consent were then 
randomly allocated to one of the study groups on the basis of 
computerized randomized list.
Inclusion Criteria:
1. ASA 1
2. Age: 20-50 years
3. Patients posted for Elective FESS
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Exclusion Criteria
1. Patients with coronary artery disease
2. Patients with diabetes
3. Patients with Hypertension
4. Patients with renal dysfunction
5. Patients with Hepatic Dysfunction
6. Patients with Bleeding Diathesis,
7. Patients with Cerebrovascular disease
8. Patients with Recurrent sinus surgery
Materials Needed
1. 18G iv Cannula
2. 18G radial artery cannula
3. 50cc Syringe
4. Infusion Pump
5. Transducer
6. 2cc, 5cc and 10cc Syringes
7. Injection Dexmedetomidine
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8. Injection Esmolol
9. Boyle’s Apparatus
10. Working laryngoscope, cuffed endotracheal tubes of 
appropriate size, Airway, suction apparatus with suction 
catheter.
11. Emergency drugs like Inj. Adrenaline, Inj. Atropine, Inj. 
Ephedrine.
12. Monitor for continuous monitoring of  Invasive blood 
pressure, ECG,Respiratory rate, Oxygen saturation.
Methodology
18 G iv Cannula was inserted and the patients started on infusion 
Ringer Lactate. Another 18G iv Cannula was inserted in the opposite 
limb for infusion of the Study drug.
18 G radial Artery Cannula was inserted for continuous 
measurement of Arterial Blood Pressure.
All patients were premedicated with Injection Glycopyrolate 
0.2mgintramuscularly 45 minutes prior to surgery, Injection Midazolam 
0.05 mg/kg intravenously and Injection Fentanyl 2 microgram/kg 
intravenously.
51
In Esmolol group, patients were given a loading dose of Esmolol 
at 1mg/kg over 1 minute followed by infusion at the rate of 0.4-0.8 
mg/kg/hour before induction. The infusion dose was titrated to obtain a 
mean arterial pressure between 55-65 mm Hg.
In Dexmedetomidine group, patients were given a loading dose 
Of dexmedetomidine at 1 microgram/kg diluted in 10 mL of 0.9 % 
Saline over 10 minutes followed by infusion at the rate 0.4-0.8 
micrograms/kg/hour before induction. The infusion dose was titrated to 
obtain a mean arterial pressure between 55-65 mm Hg.
Induction agent used in all patients in this study was Propofol. 
Propofol was administered at a dose of 1-2mg/kg until the loss of Verbal 
response. Induction dose of Propofol was recorded.
Intubation was done following administration of Injection 
Atracurium0.5 mg/kg with appropriate sized Endotracheal Tubes.
Anaesthesia was maintained with 60 % N2O/O2 mixture.
All patients were placed in 15 degree reverse Trendelenberg 
position and their nasal cavities were packed with Cottonoids, soaked 
with Epinephrine in a concentration of 1: 80,000.
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All the surgeries were performed by the same Surgeon, who was 
blinded to the hypotensive agent used, so as to ensure consistency in 
estimating the quality of the surgical field.
Infusion of the study drugs was stopped 10 minutes before the end 
of the surgery. Patients were extubated after reversal with inj 
neostigmine and inj glycopyrolate.
Parameters Monitored
1. Dose of Propofol
2. Blood Pressure- Pre-operatively, After induction, at 15 minutes,  at 
30 minutes, at 45 minutes during surgery, 5 minutes after stoppage of 
infusion of study drug, 10 minutes after stoppage of infusion of study 
drug, at the end of surgery, after extubation.
3. Heart rate - Pre-operatively, After induction, at 15 minutes,  at 30 
minutes, at 45 minutes during surgery, 5 minutes after stoppage of 
infusion of study drug, 10 minutes after stoppage of infusion of study 
drug, at the end of surgery, after extubation.
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4. Serum cortisol level intraoperatively
5. Emergence Time: It is the time interval between stoppage of the 
anaesthetic drugs and eye-opening to oral commands.
6. Quality of the surgical field- It is assessed using average category 
scale.
Average Category Scale
Score 0 - No bleeding
Score 1 - Minimal Bleeding, suctioning not required
Score 2 - Minimal Bleeding, suctioning occasionally required
Score 3 - Minimal Bleeding, repeated suctioning required
Score4 - Moderate Bleeding, repeated suctioning required, 
bleeding obscures surgical field
Score 5 - Severe Bleeding, surgery not possible as bleeding 
completely obscures the surgical field
7. PostAnaesthesia Recovery Score: it is assessed using Modified 
Aldrete Score.
1. Activity- Able to move voluntarily or on command
Four extremities 2
Two extremities 1
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No extremities 0
2. Respiration
Able to breathe deeply and cough freely 2
Dyspnea, shallow or limited breathing 1
Apnea 0
3. Circulation
Blood pressure within 20 mm Hg of Pre-Op level 2
Blood Pressure within 20-50 mm Hg of Pre-Op level 1
Blood Pressure  ± 50 mm Hg of Pre-Op level 0
4. Consciousness
Fully Awake 2
Arousable on command 1
unresponsive 0
5. Oxygen saturation
Saturation more than 92 % 2
Needs Oxygen to maintain saturation more than 90 % 1
Saturation less than 90 % with oxygen 0
Total Score- 15
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9 or more points are required for recovery to be confirmed.
Time required to attain Modified Aldrete Score of more than 9 is 
recorded.
8. Sedation Score at 15, 30 and 60 minutes after extubation is
recorded.
Sedation Score- Ramsay Sedation Score
Score 1 Patient is anxious, agitated or restless or both
Score 2 Patient is cooperative, oriented and tranquil
Score 3 Patient responds to commands only
Score 4 Patient exhibits brisk response to light, glabellar tap or loud 
auditory stimulus
Score 5 Patient exhibits sluggish response to light, glabellar tap or 
loud auditory stimulus
Score 6 Patient exhibits no response
9. The time required for first rescue analgesic in the post-operative 
period is also recorded.
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STATISTICAL ANALYSIS
Dose of propofol,  heart rate, systolic blood pressure, diastolic 
blood pressure, emergence time, post anaesthesia recovery score, 
sedation score, time for rescue analgesia. All recorded data wee entered 
using MS-excel software and analysed using SPSS(Statistical Package 
of Social Sciences,  Version 16 for windows, student’s t-test was used to 
compare the two groups on mean values of various parameters. The p-
value taken for significance is <0.05.
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RESULTS AND OBSERVATION
Our study included 50 patients,patients were randomly allocated 
into either group E(esmolol group) or group D(dexmetetomidine).Initial 
patient charecteristics such as age, weight and ASA grading were noted.
Outcomes measured are dose of propofol, heart rate and blood 
pressure,quality of surgical field, emergence time, post anesthesia 
recovery score,sedation score at 15 minutes,30 minutes and 60 minutes 
after surgery,time for rescue analgesia post operatively, serum cortisol 
intraoperatively.
PATIENT CHARECTERISTICS
AGE(student’s t test)
The average age did not differ between the two groups.
age in group  E was 3
was33.08±7.39. The difference was not statistically significant(p value 
=0.5).
Group
     Group D      
     Group E      
30
31
32
33
34
D
58
1.84±8.68 years and that of group D 
Mean T value P value
33.08±7.3         0.543            0.5
31.84±8.6
E
33.08
31.84
Mean Age
The mean 
WEIGHT(student’s t test)
The average weight did not differ between the two groups.
average weight of patients in group Ewas
weight of patients in group D was  56±9.12.
statistically significant(p value=0.
      Group          
     Group D         
      Group E      
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56
57
58
D
59
57.04±9.74 and the average 
The differences was not 
7).
mean       T value        P value
56±9.1        0.389           0.7
57.04±9.7
E
56
57.04
WT
The 
OUTCOMES MEASURED
1) Dose of propofol(student’s t test)
The inductiondose of propofol was lower in group 
mg/kg)  when compared with group E(
statistically significant (p value<0.001).
Group
Group D
Group E
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
D
60
D(
1.65±0.13 mg/kg),which was 
mean T value P value
1.24±0.10 12.20 0.00
1.65±0.13
E
1.2424
1.6539
1.24±0.10 
2) HEART RATE(student’s t test
Heart rates were compared between two groups preoperatively, 
after induction,at(15 minutes,30 minutes,45 minutes
minutes and 10 minutes after stoppage of study drug), at end of 
surgery,after extubation.  
Comparison showed no statistically significant differences in 
heart rate between two groups preoperatively(p value=0.058)
80
81
82
83
84
85
86
87
88
D
83.04
61
)
)during surgery,at
E
87.52
(5 
Comparison showed no statistically
heart rate between two groups after intubation(p value=0.27)
Comparison showed no statistically significant differences in     
heartrate between two groups at 15 minutes 
(pvalue=0.082)
70
70.5
71
71.5
72
72.5
73
73.5
74
62
62.5
63
63.5
64
64.5
65
65.5
66
66.5
67
67.5
D
62
significant differences in 
.
during
D E
73.6
71.32
E
67.12
64
surgery 
Comparison showed no st
heart rate between two groups at 30 minutes during 
surgery(pvalue=0.05)
Comparison showed no statistically significant differences in 
heart rate between two groups at 45 minutes during surgery( p 
value=0.09).
62
62.5
63
63.5
64
64.5
65
65.5
66
66.5
67
67.5
D
63
atistically significant differences in     
E
67.12
64
Comparison showed statistically significant differences in heart 
rate between two groups at 5 minutes  after stoppage of study drug 
(p value<0.001).Heart rate’s were significantly hi
group D.
Comparison showed statistically significant differences in heart 
rate between two groups at 10 minutes  after stoppage of study drug 
57.5
58
58.5
59
59.5
60
60.5
61
61.5
62
62.5
63
D
56
58
60
62
64
66
68
64
gher in group E than  
E
62.52
59.44
D E
60.44
66.08
(p value=0.002).Heart rate’s were significantly higher in group E than  
group D.
Comparison showed statistically signifi
rate between two groups at end of surgery(p value=0.002).
were significantly higher in group E than group D.
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64
66
68
70
72
64
65
66
67
68
69
70
71
72
73
74
65
cant differences in heart 
H
D E
65.12
70.96
D E
67.24
73.12
eart rate’s 
Comparison showed statistically significant differences in heart 
rate between two groups at end of surgery(
were significantly higher in group E than group D.
62
64
66
68
70
72
74
76
78
80
82
D
68.76
66
p value<0.001).H
E
81.12
eart rate’s 
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Time Group Mean T value p value
Pre operative D 83.04±8.1 1.944 0.058
E 87.52±8.1
After intubation D 73.6±6.8 1.117 0.27
E 71.32±7.5
15 min of surgery D 67.12±5.7 1.777 0.082
E 64±6.6
30 min of surgery D 64.44±8.5
62.56±6.1
2.34 0.05
E
45 min of surgery D 62.52±6.0 1.732 0.09
E 54.44±6.5
5 min after stoppage D 60.44±6.7 3 0.00
E 66.08±6.5
10 min after stoppage D 65.12±5.8 3.284 0.002
E 70.96±6.6
At end of surgery D 67.27±5.7 3.351 0.002
E 73.12±6.6
After extubation D 68.76±5.3 7.576 0.00
E 81.12±6.1
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83.04
73.6
67.12
64.44
62.52
60.44
65.12
67.24
68.76
87.52
71.32
64
62.56
59.44
66.08
70.96 73.12 81.12
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3. COMPARISON OF SYSTOLIC BLOOD 
PRESSURE(student’s t test)
Systolic blood pressure was compared between two groups 
preoperatively,after induction,
during surgery,at(5 minutes and 10 minutes after stoppage of study 
drug), at end of surgery,
Comparison showed n
systolic blood pressure between two groups pre operatively (p 
value=0.98)
Comparison showed no statistically significant differences in 
systolic blood pressure between two groups after intubation (p 
value=0.06).
123.2
123.22
123.24
123.26
123.28
123.3
69
at(15 minutes,30 minutes,45 minutes ) 
after extubation.
o statistically significant differences in 
D E
123.24
123.32
Comparison showed no statistically significant differences in 
systolic blood pressure between two groups at 15 minutes during 
surgery (p value=0.05).
108
109
110
111
112
113
114
115
D
91
91.5
92
92.5
93
93.5
70
E
110.72
114.32
D E
91.72
93.08
Comparison showed no statistically significant differences in 
systolic blood pressure between two gr
surgery (p value=0.08).
Comparison showed no statistically significant differences in 
systolic blood pressure between two groups at 45 minutes during 
surgery (p value=0.17).
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87.5
88
88.5
89
89.5
90
90.5
88.8
89
89.2
89.4
89.6
89.8
90
90.2
90.4
90.6
90.8
91
71
oups at 30 minutes during 
D E
88.36
90.28
D E
89.6
90.92
Comparison showed statistically significant differences in systolic 
blood pressure between two groups at 5 minutes after stoppage of study 
drug.Systolic blood pressure was significantly higher in group E than 
group G  (p value<0.001).
Comparison showed 
blood pressure between two groups at 10 minutes after stoppage of 
study drug. Systolic blood pressure was significantly higher in group E 
than group G  (p value<0.001).
0
20
40
60
80
100
120
D
72
statistically significant differences in systolic 
E
92.48
112.16
Comparison showed statistically sig
blood pressure between two groups at end of surgery.
pressure was significantly higher in group E than group G  (p 
value<0.001).
0
20
40
60
80
100
120
D
0
20
40
60
80
100
120
73
nificant differences in systolic 
Systolic 
E
94.32
115.32
D E
95.32
116.4
blood 
Comparison showed statistically significant differences in systolic 
blood pressure between two groups after extubation.
pressure was significantly higher in group E than group G  (p 
value<0.001).
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Systolic blood 
E
101.2
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Time Group Mean T value P value
Pre operatively
D 123.24±10.8 0.03 0.98
E 123.32±7.6
After intubation D 110.72±5.5 1.92 0.06
E 114.32±6.7
15 min of surgery D 91.72±4.9 1.91 0.05
E 93.08±5.5
30 min of surgery D 88.36±3.5 1.813 0.08
E 90.28±3.8
45 min of surgery D 89.6±2.9 1.407 0.17
E 90.92±3.6
5 min after stoppage D 92.48±2.6 14.54 0.00
E 112.16±6.1
10 min after stoppage D 94.32±2.8 16.69 0.00
E 115.32±5.6
At end of surgery D 95.32±3.0 15.65 0.00
E 116.4±5.4
After extubation D 101.2±3.7
118.24±6.3
11.53 0.00
E
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COMPARISON OF DIASTOLIC BLOOD PRESSURE(student’s
test)
Diastolic blood pressure was compared between two groups 
preoperatively, after induction,
during surgery, at(5 minutes and 10 minutes after stoppage of study 
drug), at end of surgery,
Comparison showed no statistically significant differences in 
diastolic blood pressure between two groups pre operatively (p 
value=0.27).
75
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77
at(15 minutes,30 minutes,45 minutes) 
after extubation.
E
76.36
78.48
t 
Comparison showed no statistically significant differences in 
diastolic blood pressure between two groups after in
value=0.31).
Comparison showed no statistically signif
diastolic blood pressure between two groups at 15 minutes during 
surgery (p value=0.54).
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tubation (p 
icant differences in 
D E
71.88
73.56
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Comparison showed no statistically significant differences in 
diastolic blood pressure between two groups at 30 minutes during 
surgery (p value=0.15).
Comparison showed no statistically signi
diastolic blood pressure between two groups at 45 minutes during 
surgery (p value=0.19).
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Comparison showed statisti
diastolic blood pressure between two groups at 5 minutes after stoppage 
of study drug .diastolic blood pressure was significantly higher in group 
E than group G  (p value<0.001).
Comparison showed statistically 
diastolic blood pressure between two groups at 10 minutes after 
stoppage of study drug .diastolic blood pressure was significantly higher 
in group E than group G  (p value<0.001).
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Comparison showed statistically significant dif
diastolic blood pressure between two groups at end of surgery .diastolic 
blood pressure was significantly higher in group E than group G  (p 
value<0.001).
Comparison showed statistically significant differences in 
diastolic blood pressure between two groups after extubation .
blood pressure was significantly higher in group E than group G  (p 
value<0.001).
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Time Group mean T value P value
Pre op D 76.36±6.5 1.118 0.27
E 78.48±6.8
After intubation D 71.88±5.9 1.023 0.31
E 73.56±5.6
15 min of surgery D 60.24±5.5 0.624 0.54
E 61.48±8.2
30 min of surgery D 58.92±3.7 1.452 0.15
E 60.52±4.0
45 min of surgery D 59.6±4.5 1.345 0.19
E 61.16±3.5
5 min after stoppage D 61.28±4.1 7.624 0.00
E 72.72±6.6
10 min after stoppage D 61.2±4.0 12.041 0.00
E 77.4±5.3
At end of surgery D 64.48±3.3 12.604 0.00
E 79.72±5.0
After extubation D 67.48±3.7 11.05 0.00
E 80.08±4.3
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4) QUALITY OF SURGICAL FIELD
SCALE(student’s t test) 
Comparison of quality of surgical field showed no statistical 
difference between two groups.
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5) EMERGENCE TIME
Comparison of emergence time showed statistically significant 
differences between two groups.
higher in group D than
Group
  Group D
  Group  E
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(student’s t test)
Emergence time was significantly 
group E (P value<0.001).
Mean T value P value
13.14±1.1     15.57       0.00
  7.62±1.3
E
13.14
7.62
Emergence time
6) POST ANESTHESIA RECOVERY SCORE
ALDRETE SCORE(student’s t test)
Comparison showed statistically significant differences between 
two groups in the time  to achieve modified aldrete score of    
time was significantly
value  <0.001).
Group
  Group D
   Group E
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Post anesthesia recovery score
86
-MODIFIED 
higher in group D compared with group E
Mean T value P value
   15.4±1.8      10.89       0.00
   10.86±0.9
E
15.4
10.86
≥ 9.The 
  (P 
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7) SEDATION SCORE-RAMSAY SEDATION 
SCORE(student’s t test)
Comparison between two groups showed that there was  
statistically significant differences in sedation scores at 15 minutes 
(p value <0.001)and 30 minutes (p value=0.01)after surgery.
Sedation scores were significantly higher in group D than group 
E.There was  no statistically significant differencein sedation score 
between two group’s at 60 minutes after surgery.
Time Group mean T value P value
15 minutes Group D 2.76±0.4 3.05 0.00
Group E 2.36±0.4
30 minutes Group D 2.64±0.4 2.683 0.01
Group E 2.28±0.4
60 minutes Group D 2
Group E 2
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8) RESCUE ANA
Comparison between two groups showed that there was 
statistically significant differences in the time for rescueanalgesia 
(p value<0.001).The time for 
in group D than group E
     Group
    Group D
    Group E
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LGESIA(student’s t test)
rescue analgesia was significantly higher 
.
      Mean     T value     P value
   64.4±7.9      12.28        0.00
  40.64±5.5
E
64.4
40.64
Rescue Analgesia
9) SERUM CORTISOL
Comparison between two groups showed that there was no 
statistically significant difference in serum cortisol levels 
intraoperatively (p value=0.07).
Group
Group D
Group E
0
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2
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D
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(student’s t test)
Mean T value P value
4.04±0.5 1.83 0.07
3.75±05
E
3.75
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DISCUSSION
Functional  endoscopic sinus surgery is one of the routinely 
performed surgeries.The use of hypotensive anesthesia during 
endoscopic sinus surgery has greatly reduced blood loss and improved 
visibility and quality of surgical field. Many studies have been published 
,which have stated the advantages of employing hypotensive anesthesia 
during endoscopic sinus surgery.
In our study we have compared the effects of dexmedetomidine 
given at a loading dose of 1microgram/kg over 10 minutes followed by 
infusion at 0.4-0.8 microgram/kg /hr with esmolol given at a loading 
dose of 1mg/kg over 1 minute followed by infusion at 0.4-0.8 mg/kg/hr 
in induced hypotension for endoscopic sinus surgery.
The patients were comparable in both groups with regard's to age 
and weight.
DOSE OF PROPOFOL
In our study, we found that the dose of propofol required for 
induction was significantly lower in dexmedetomidine group than 
esmolol group. The dose of propofol in dexmedetomidine group was 
(1.24±0.10 mg/kg) and it esmolol group it was (1.65±0.13 mg/kg).
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This was consistent with the results obtained by
1) Suvadeep et al(2013) studied the effects of intraoperative 
dexmedetomidine infusion on requirement of propofol for 
maintainance of optimum depth of anesthesia during spine 
surgeries and concluded that dose of propofol was significantly 
reduced with  the use of dexmedetomidine infusion.
2) Kanka et al(2009) studied the effects of dexmedetomidine on 
anaesthetic requirements in patients undergoing cardiovascular 
surgery and concluded that the dose of propofol and fentanyl were 
significantly lower with the use of dexmedetomidine.
HEART RATE AND BLOOD PRESSURE
In our study, we found that the heart rate and blood pressure 
decreased significantly following administration of loading dose of 
esmolol and dexmedetomidine followed infusionheart rate and blood 
pressure intraoperatively (at 5 minutes and 10 minutes after stoppage of 
infusion) , at the end of surgery and after extubation  were significantly 
lower in dexmedetomidine group than esmolol group.
This was consistent with the results obtained by
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1) Shen et at(2001) studied the effects of intravenous infusion of 
esmolol on patients undergoing endoscopic sinus surgery and found 
that heart rate and blood pressure significantly decreased with 
esmolol infusion.
2) Malhotra et al(2013)studied the effects of dexmedetomidine on 
hypotensive anesthesia in patients undergoing hypotensive anesthesia 
andfound that mean arterial pressure and heart rate was significantly 
lower with use of dexmedetomidine .
QUALITY OF SURGICAL FIELD
In our study,the quality of surgical field was assessedusing 
average category scale and we found that both esmolol and 
dexmedetomidine  were effectivein producing a surgical field with
improved visibility(average category scale=2)
This is consistent with the results produced by
1) Farah nasreen et al (2009) studied the effects of dexmedetomidine 
for patients undergoing middle ear surgery with hypotensive  
anesthesia and found that the quality of surgical field was greatly 
improved with use of dexmedetomidine.
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2) Boezaart et al(1995) made a comparative study between sodium 
nitroprusside and esmolol  using inducing hypotension in functional 
endoscopic sinus surgery and found that superior surgical conditions 
were seen with esmolol even with mild hypotension(MAP>65 mm 
hg).
EMERGENCE TIME
In our study, we found that the emergence time wassignificantly 
prolonged in dexmedetomidine group (13.14±1.13 minutes)than esmolol 
group(7.62±1.36 minutes).
This was consistent with the results obtained by
1) Abdulla aydin ozcan et al(2012) made a comparative study between 
remifentanil and dexmedetomidine for controlled hypotension in 
patients undergoing endoscopic sinus surgery and found that 
recovery time was prolonged in dexmedetomidine group than 
remifentanil group.
POST ANESTHESIA RECOVERY SCORE
In our  study post anesthesia recovery score was assessed using 
modified aldrete score .we found  that post anesthesia recovery (time to 
achieve modified aldrete score of ≥9) was significantly higher in 
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dexmedetomidine group(15.4±1.84 minutes) than esmolol group
(10.86±0.97 minutes).
This was consistent with the results obtained by
1) Koi io et al(2009) made a comparative study between esmolol and 
dexmedetomidine  combined with desflurane for controlled 
hypotension during tympanoplasty in adults and found that esmolol 
group had shorter recovery time than dexmedetomidine group.
2) Turan et al(2007) made a comparative study between esmolol,
remifentanil and dexmedetomidine in controlled hypotensive 
anesthesia and found that post extubation recovery score was longer 
in dexmedetomidine  group than esmolol and remifentanil group.
SEDATION SCORE
In our study post operative sedation scores were assessed using 
Ramsay sedation score. we found that sedation scores were higher in 
dexmedetomidine group than esmolol group at 15 minutes(2.76±0.43 
vs2.36±0.49) and 30 minutes(2.64±0.49 vs2.28±0.45) and there was no 
difference in  sedation score between two groups at 60 minutes after 
surgery.
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This was consistent with the results obtained by
1) Cr patel et al(2012)studied the effect of intravenous infusion of 
dexmedetomidine of on perioperative haemodynamic changes and 
post operative recovery and found that post operative sedation was 
significantly higher in dexmedetomidine group than control group.
TIME FOR RESCUE ANALGESIA
In our study,the time for rescue analgesia was significantly longer 
in dexmedetomidine group (64.4±7.91 minutes) than esmolol 
group(40.64±5.56 minutes).
This was consistent with the results obtained by
1) Gurbet et al(2006) made a study on intraoperative use of 
dexmedetomidine on post operative analgesic requirements  and 
found that requirement of morphine in the post operative period 
was lower in dexmedetomidine group and concluded that  
dexmedetomidine provides excellent post operative analgesia 
without increasing side effects.
2) Gupta et al(2013) studied the effect on intraoperative 
dexmedetomidine on post operative recovery in children 
undergoing spinal surgery and found that post operative agitation 
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and pain scores were lower in dexmedetomidine group and 
requirement of analgesic’s and time for rescue analgesia was 
longer in dexmedetomidine group.
INTRA OPERATIVE SERUM CORTISOL
In our study, there was no significant differences between two 
group’s with respect to intraoperative serum cortisol levels.
           This is consistent with results obtained by
1) Sarpkaya et al (2010) studied the effects of perioperative use of 
dexmedetomidine on surgical stress response in hypertensive 
patients and found that serum cortisol levels were lower in 
dexmedetomidine group than control group.
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                               SUMMARY    
              This study was undertaken to compare dexmedetomidine with 
esmolol in controlled hypotension for functional endoscopic sinus 
surgery.
                A total of 50 patients were randomly allocated into two groups 
.Group D received dexmedetomidine at a loading dose of 1 
microgram/kg followed by infusion at a dose of 0.4-0.8 
microgram/kg/hr.
                 Group E received esmolol at a loading dose of 1mg/kg 
followed by infusion at 0.4-0.8 mg /kg/hr.
                  Various parameters like dose of propofol, intraoperative 
heart rate and blood pressure, quality of surgical field, emergence time,
post anaesthesia recovery score, sedation score, intra operative serum 
cortisol, time for  rescue analgesia was recorded.
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  The observation noted were as follows
 The induction dose of propofol was lower in dexmedetomidine 
group than esmolol ,which was statistically significant.
 Heart rate and blood pressure was significantly lower in 
dexmedetomidine group than esmolol group at 5 and 10 min’s 
after stoppage of infusion, at end of surgery and after extubation.
 The quality of surgical field was comparable between two groups.
 Emergence time was significantly prolonged in dexmedetomidine 
group than esmolol group.
 Time to achieve post anaesthesia recovery score (modified aldrete 
score>9)was significantly higher in dexmedetomidine group than 
esmolol group.
 Sedation score’s were higher in dexmedetomidine group than 
esmolol group at 15 min’s and 30 min’s after extubation.
 Time for rescue analgesia was significantly higher in 
dexmedetomidine group than esmolol group.
 Intra operative serum cortisol level’s were comparable between 
two group’s.
 No adverse complications were noted in both group’s.  
100
CONCLUSION
The observation of this study is that both esmolol and 
dexmedetomidine can be effectively used in induced hypotension for 
functional endoscopic sinus surgery. Both groups were comparable with 
respect to quality of surgical field and intraoperative haemodynamics.
This study also shows that dexmedetomidine has added advantage 
of sedative,analgesic and reduced requirement of anaesthetic agents 
when compared with esmolol. Post operative recovery scores and 
sedation scores were significantly higher and time required for rescue 
analgesia was also prolonged with dexmedetomidine than esmolol.
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PROFORMA
Name:
Age:
Sex:
Weight:
Diagnosis:
Surgery:
MPC:
ASA PS class:
Group:
    parameters              
  Dose of propofol
    Heart rate Pre op
After induction 
15 min of surgery
30 min of surgery
45 min of surgery
5 min after stop
10 min after stop
At end of surgery
After extubation
    Blood pressure Pre op
After induction 
15 min of surgery
30 min of surgery
45 min of surgery
5 min after stop
10 min after stop
At end of surgery
After extubation
   Intra op plasma    
   cortisol 
   Quality of surgical 
    field
   Emergence time
    Post op recovery 
    score
     Sedation score 15 minutes
30 minutes
60 minutes
    Time for rescue 
    analgesic
MASTER CHART   GROUP D
group Name age sex wt
Sbp 
preop
Dbp 
preop
Sbp after 
int
Dbp after
int sbp15mi dbp15mi sbp30mi
dbp30
min sbp45mi dbp45mi
sbp5
min af 
stop
dbp5mi
n af 
stop
sbp10mi
af stop
dbp10
min af 
stop
Sbp at 
end
Dbp at 
end Sbp af ex Dbp af ex
1 Perumal 38 1 50
120 72 108 70 90 58 90 56 90 58 94 60 96 62 98 70 102 71
1 Thamilarasi 31 2 65
120 70 110 71 93 52 90 54 90 58 98 64 96 60 100 62 103 63
1 Verrakannan 21 1 50
125 60 106 70 98 54 86 52 80 53 98 58 100 60 96 70 98 74
1 Gajendran 42 1 70
120 70 110 70 96 58 80 52 80 54 92 60 93 65 94 66 97 70
1 Rukumani 36 1 40
116 78 105 70 88 55 88 56 80 58 94 63 93 60 96 66 98 63
1 Raguram 26 1 60
120 70 106 70 89 58 85 52 84 58 90 66 94 68 96 65 99 66
1 Latha 30 2 50
110 78 100 74 90 50 88 52 86 50 90 54 93 62 98 60 103 70
1 Sasikala 34 2 55
106 72 102 66 91 58 80 58 88 54 90 62 96 67 92 64 105 70
1 Thenmozhi 40 2 45
120 70 120 68 99 52 90 56 80 54 96 62 95 60 93 60 103 63
1 Sathish 30 1 75
114 70 110 70 84 58 88 56 85 50 90 62 93 60 98 62 98 66
1 Karthick 28 1 65
120 71 117 66 82 56 84 56 88 54 94 64 98 60 102 62 103 63
1 Manimaran 45 1 55
120 72 111 60 89 58 86 52 90 56 92 58 90 57 94 69 98 66
1 Dinesh 23 1 60
117 80 110 70 93 58 90 60 88 54 90 62 93 63 98 60 101 65
1 Suganya 27 2 50
110 70 108 70 90 60 85 54 92 56 94 60 98 61 90 64 102 66
1 Vijayalakshmi 33 2 40
120 68 112 66 92 54 80 58 92 54 95 58 90 50 94 63 104 65
1 Subash 27 1 60
120 76 120 72 84 58 80 54 86 60 90 64 93 70 90 66 96 68
1 Nithya 30 2 50
120 78 116 70 83 60 84 60 88 63 92 66 97 62 94 60 97 64
1 Geetha 36 2 65
117 70 112 72 86 54 84 60 86 64 90 68 93 60 96 63 98 68
1 Vularmani 48 2 50
112 80 104 72 90 58 82 60 90 56 92 60 95 63 94 64 98 63
1 Umakannan 40 1 60
114 70 107 66 94 63 90 60 82 64 94 60 97 60 98 68 101 70
1 Lakshmi 37 2 50
126 80 112 66 84 60 85 63 88 60 90 62 92 60 96 64 98 67
1 Senthamarai 43 2 55
120 79 114 72 88 56 84 58 88 70 93 72 98 66 90 70 106 73
1 Kalyani 23 2 60
121 84 107 70 96 58 90 62 94 56 95 55 95 60 94 68 110 74
1 Karunakaren 35 1 70
109 70 104 76 90 58 90 62 94 58 91 55 90 56 94 60 108 74
1 Kannan 24 2 50
117 85 112 80 84 62 86 56 90 60 88 57 90 58 98 66 104 65
Pre op hr Af intubation Hr 15 min Hr 30 min Hr 45 min Hr 5 min af stop Hr 10 min af stop At end of surgery After extubation
86 72 62 62 56 56 62 64 67
84 70 62 62 56 56 64 66 66
86 66 60 66 54 50 63 68 68
84 66 60 68 54 54 64 65 66
80 70 62 70 56 60 68 70 71
70 70 60 60 56 58 63 65 64
76 66 62 60 58 58 61 64 66
80 66 62 62 56 54 62 65 67
84 70 66 66 58 60 67 69 70
90 70 62 70 56 60 71 73 71
86 66 60 74 58 60 75 77 78
82 66 60 63 58 60 60 62 63
76 66 60 58 55 55 60 64 65
86 70 60 67 58 65 66 68 69
68 60 56 52 50 50 54 56 60
74 66 60 61 59 60 61 62 65
70 60 56 54 51 53 55 57 60
80 72 64 64 58 64 65 66 68
78 66 60 66 56 69 70 73 71
88 66 60 69 58 72 71 72 74
92 66 60 71 58 68 70 73 75
90 66 60 67 60 71 72 74 76
76 66 60 58 56 56 57 59 63
94 70 62 71 60 72 73 74 78
92 72 64 70 58 70 74 75 78
Average category scale Dose of propofol Emergence time Postanesthesia recovery score Rescue analgesia S 15 mins S 30 mins S 60 mins Serum cortisol
2 70 12 15 60 3 3 2 4
2 80 12 15 65 3 2 2 3
2 60 12 14 55 3 3 2 3
2 80 13 14 65 3 3 2 4
2 50 14 16 70 3 3 2 4
2 75 15 17 75 3 3 2 5
2 65 13 14 80 3 3 2 5
2 65 16 16 65 3 3 2 4
2 60 11 15 60 3 2 2 4
2 90 13 14 60 2 3 2 5
2 80 13 15 70 3 3 2 4
2 75 14 16 75 2 2 2 3
2 70 14 16 62 3 3 2 4
2 60 13 11 45 3 3 2 4
2 60 13 18 80 2 2 2 4
2 70 14 15 55 3 3 2 5
2 60 14 16 60 3 2 2 5
2 70 15 16 65 3 3 2 4
2 70 14 17 70 2 2 2 4
2 65 12 11 60 3 3 2 4
2 60 13 16 65 2 2 2 4
2 70 13 18 65 3 3 2 4
2 70 13 17 60 2 2 2 4
2 80 14 18 63 3 3 2 3
2 70 13 18 60 3 2 2 4
GROUP E
group Name age sex wt
Sbp 
pre op
Dbp pre 
op
Sbp after 
intu
Dbp after 
intubation
Sbp 15 
min
Dbp 15 
min
Sbp 30 
min
Dbp 30 
min
Sbp 45 
min
Dbp 45 
min
Sbp 5 min 
af stop
Dbp 5 min 
af stop
Sbp 10 
min af 
stop
Sbp at 
end
Dbp 
at 
end
Dbp 
at 
end
Sbp af 
ex
2 Rajasekar 21 1 85
120 80 110 70 96 52 90 50 94 54 106 57 107 70 108 114 78
2 Bala 50 2 40
120 70 100 74 92 58 88 54 91 54 109 62 106 64 112 120 74
2 sivakumar 21 1 50
130 80 110 76 96 56 94 60 93 62 110 63 114 71 116 126 80
2 Suganthi 27 2 60
126 74 116 76 100 50 93 58 90 54 104 70 116 81 114 124 80
2 Mythili 23 2 60
117 80 112 76 104 76 91 60 88 60 108 74 117 83 124 120 84
2 Tamilarasi 31 2 65
128 76 120 78 108 86 88 58 84 62 112 76 120 76 126 118 81
2 Jothi 31 2 54
108 76 106 80 98 58 99 60 93 62 120 72 114 76 117 118 80
2 Mohanapriya 22 2 45
114 72 110 72 90 56 80 58 84 62 107 78 108 82 110 100 70
2 Revathi 40 2 50
120 80 110 70 90 62 93 64 90 66 106 84 110 82 111 110 84
2 Suresh 27 1 60
116 73 114 74 96 63 90 60 92 62 102 78 106 76 121 124 82
2 Ramesh 30 1 55
127 90 120 76 86 60 85 65 84 60 109 70 114 76 110 116 83
2 Ramkumar 34 1 60
134 94 130 80 94 70 90 62 94 68 118 80 111 86 112 114 82
2 Ratnavel 47 1 68
130 82 126 76 90 72 92 67 90 61 112 72 114 76 111 120 86
2 Chitra 26 2 43
121 70 120 88 87 57 90 56 94 60 116 71 118 70 110 122 72
2 Shobana 28 2 48
114 80 110 70 88 53 92 58 96 60 121 70 118 78 120 124 84
2 Sukumar 22 1 50
112 68 110 62 92 51 90 56 88 60 108 81 126 70 124 126 79
2 Ravi 33 1 55
126 70 112 70 94 58 93 62 95 66 113 70 120 76 126 120 76
2 Ganesh 38 1 60
120 77 114 72 91 60 96 62 94 63 111 74 114 80 120 124 80
2 Selvakumar 40 1 53
114 84 106 80 95 56 90 62 93 60 110 71 118 81 123 116 80
2 Prabu 26 1 70
120 86 120 70 96 66 93 62 90 64 126 76 120 81 114 115 84
2 Karpagam 38 2 62
128 78 118 71 85 60 90 64 92 60 110 71 126 84 125 106 84
2 Praveen 21 1 68
132 80 120 76 87 64 88 62 85 60 114 76 116 80 110 126 83
2 Senthil 35 1 60
130 84 114 70 93 68 83 68 90 60 112 62 114 76 116 120 72
2 Sridhar 38 1 50
136 88 120 70 90 62 90 62 94 63 126 78 124 84 120 120 84
2 Sakthivel 47 1 55
120 70 110 62 89 63 89 63 95 66 114 82 112 76 110 113 80
Preop hr Af intubation Hr 15 min Hr 30 min Hr 45 min Hr 5 min af stop Hr 10 min af stop At end of surgery After extubation
92 72 64 70 58 70 74 75 78
84 68 64 60 60 68 72 72 76
90 70 62 60 58 66 70 74 74
96 80 72 70 72 80 86 86 88
90 76 70 68 66 70 74 76 80
80 70 64 62 62 68 70 72 80
86 76 66 64 66 70 74 74 90
92 80 68 62 60 64 68 70 82
72 60 52 52 50 58 64 66 76
86 70 66 62 60 64 66 70 78
78 62 56 52 50 56 62 64 70
98 72 60 58 56 62 66 68 76
104 86 72 68 64 70 76 74 80
78 64 56 54 52 60 66 64 78
84 70 60 56 52 56 60 64 70
90 72 62 60 58 66 70 72 76
96 80 72 66 64 70 76 78 86
100 84 76 70 70 76 82 84 90
92 72 68 64 64 72 78 80 90
80 64 60 54 52 60 64 68 80
86 66 58 52 54 62 66 70 82
84 60 56 54 56 62 68 72 82
78 64 60 56 54 64 70 70 80
90 75 70 66 68 76 80 84 90
96 80 74 70 66 74 80 86 90
78 62 56 54 52 58 66 70 84
Average category scale Dose of propofol Emergence time
Postanesthesia recovery 
score Rescue analgesia S 15 mins S 30 mins S 60 mins Serum cortisol
2 70 13
18 60 3 2 2 4
2 150 5
10 35 2 2 2 3
2 70 7
11 40 3 3 2 4
2 75 7
11 42 2 2 2 5
2 100 8
12 30 2 2 2 3
2 90 6
9 45 3 3 2 4
2 100 9
11 40 2 2 2 4
2 90 8
10 50 2 2 2 3
2 80 6
11 35 2 2 2 3
2 80 7
11 45 3 3 2 3
2 110 8
12 40 2 2 2 3
2 80 9
12 46 2 2 2 4
2 90 6
13 48 2 2 2 4
2 100 6
11 35 3 3 2 4
2 70 8
10 30 3 2 2 3
2 90 9
11 40 2 2 2 3
2 90 10
11 45 2 2 2 3
2 100 8
12 40 2 2 2 3
2 90 7
12 35 3 3 2 4
2 80 8
13 45 2 2 2 4
2 120 8
12 50 2 2 2 4
2 100 9
11 40 3 2 2 4
2 120 10
11 45 2 2 2 4
2 100 9
10 40 3 3 2 4
2 90 7
9 40 2 2 2 3
2 90 8
10 35 3 3 2 5
